Athenex宣佈委任Daniel Von Hoff博士為Axis Therapeutics Limited的科學顧問委員會主席

Ads

You May Also Like

IVD Market in China, 2022

Dublin, May 14, 2018 (GLOBE NEWSWIRE) -- The "IVD in China" report has been ...

Incysus Granted European Patent Covering its Drug Resistant Immunotherapy (DRI) Technology

HAMILTON, Bermuda, April 12, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused ...

MacroGenics Presents Data from Phase 1 Study of MGD010 at Annual European Congress of Rheumatology (EULAR 2016)

Bispecific molecule based on DART® platform simultaneously targets B-cell antigens, CD32B and CD79B MGD010 ...